IDXX Q4 2022 Earnings — IDEXX Laboratories, Inc. Revenue & Financial Results | Market Cap Arena

IDXXIDEXX Laboratories, Inc.

$48B

Q4 2022 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$829M+3.4% YoY

Gross Profit

$485M58.5% margin

Operating Income

$227M27.3% margin

Net Income

$172M20.8% margin

EPS (Diluted)

$2.05

QoQ Revenue Growth

-1.6%

Cash Flow

Operating Cash Flow

$173M

Free Cash Flow

$134M

Stock-Based Comp.

$13M

Balance Sheet

Total Assets

$2.7B

Total Liabilities

$2.1B

Stockholders' Equity

$609M

Cash & Equivalents

$113M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$829M	$801M	+3.4%
Gross Profit	$485M	$456M	+6.2%
Operating Income	$227M	$199M	+13.7%
Net Income	$172M	$163M	+5.8%

Revenue Segments

Instrument Rebate Programs

$3M100%

Geographic Segments

UNITED STATES

$537M65%

EMEA

$159M19%

Asia Pacific

$79M10%

CANADA

$34M4%

Latin America

$20M2%